PIEZO1 and pericardial effusion: Effects of this type might be relevant to the heart because of PIEZO1’s role in pericardial effusion (Ranade et al. 2014a; Ludlow et al. 2023), and the suggestion that lymphatic stimulators may accelerate the clearance of damage products and unwanted inflammatory mediators after cardiac ischemia (Cooper et al. 2024).